Curexa Pharmacy News
Robert Cimorelli, RPh., SVP of Regulatory and Strategic Operations, Joins Curexa Pharmacy’s Executive Team
503A and 503B Compounding Expertise To Fuel Safety, Compliance, and Expansion [...]
Curexa Pharmacy Expands Leadership with New Board Member Rachel Sherman, MD, MPH, FACP
Leading 503A Compounding Pharmacy Welcomes Medical Product and Development Regulation Expert as Newest Board [...]
Pouschine Cook Capital Management Announces Investment in Curexa Pharmacy
Led by Co-founder and Chief Executive Officer, Mark K. Taylor, R.Ph., Curexa is [...]
Curexa Pharmacy Achieves Full URAC Specialty Pharmacy Accreditation
Curexa® Pharmacy, a pharmacy with industry revered clinical programs and extraordinary patient care, [...]
